Volume 14, Issue 6 (November 2012) 14, 805–806; 10.1038/aja.2012.113

Enzalutamide (formerly MDV3100) as a new therapeutic option for men with metastatic castration-resistant prostate cancer

Jeanny B Aragon-Ching

Department of Medicine, Division of Hematology and Oncology, George Washington University Medical Center, Washington, DC 20037, USA

Correspondence: Dr JB Aragon-Ching, (jaragonching@mfa.gwu.edu)

published online 8 October 2012